Ma Joseph D, Lee Kelly C, Kuo Grace M
University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences and University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences.
PLoS Curr. 2010 Dec 7;2:RRN1203. doi: 10.1371/currents.RRN1203.
Abacavir is a nucleoside reverse transcriptase inhibitor used for combination antiretroviral therapy for treating human immunodeficiency virus (HIV) infection. An adverse effect from abacavir is a treatment-limiting hypersensitivity reaction, which can be severe and potentially life-threatening. Abacavir-induced hypersensitivity reaction has been associated with the presence of the major histocompatibility complex class I allele HLA-B5701. A screening test for the HLA-B5701 allele can assist clinicians to identify patients who are at risk of developing a hypersensitivity reaction to abacavir.
阿巴卡韦是一种核苷类逆转录酶抑制剂，用于联合抗逆转录病毒疗法治疗人类免疫缺陷病毒（HIV）感染。阿巴卡韦的一种不良反应是限制治疗的超敏反应，这种反应可能很严重，甚至有潜在的生命危险。阿巴卡韦诱导的超敏反应与主要组织相容性复合体I类等位基因HLA - B5701的存在有关。对HLA - B5701等位基因进行筛查试验可帮助临床医生识别有发生阿巴卡韦超敏反应风险的患者。
